Imunon, Inc. (IMNN)

Imunon Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	5.84	11.49	19.59	17.16	6.88
Short-Term Investments	9.86	22.75	29.8	0	7.99
Cash & Cash Equivalents	15.7	34.25	49.39	17.16	14.86
Cash Growth	-54.17%	-30.66%	187.75%	15.50%	-46.18%
Other Current Assets	2.55	2.53	2.56	1.66	1.37
Total Current Assets	18.24	36.78	51.95	18.82	16.24
Property, Plant & Equipment	2.35	0.7	1.17	1.34	1.84
Long-Term Investments	0	4.5	6	0	0
Goodwill and Intangibles	0	0	0	2.09	2.32
Other Long-Term Assets	1.33	1.99	14.93	15.27	17.89
Total Long-Term Assets	3.68	7.2	22.1	18.7	22.04
Total Assets	21.92	43.98	74.05	37.53	38.28
Accounts Payable	3.52	3.59	2.55	2.24	2.86
Deferred Revenue	0	0	0.5	1	1.5
Current Debt	0.49	1.66	0.55	1.55	2.23
Other Current Liabilities	3.39	4.79	3.17	1.96	1.3
Total Current Liabilities	7.39	10.04	6.77	6.75	7.89
Long-Term Debt	1.14	4.61	6.09	4.64	9.11
Other Long-Term Liabilities	0	0	5.4	7.52	6.72
Total Long-Term Liabilities	1.14	4.61	11.48	12.16	15.82
Total Liabilities	8.53	14.65	18.25	18.92	23.72
Total Debt	1.62	6.27	6.63	6.19	11.34
Debt Growth	-74.07%	-5.54%	7.09%	-45.35%	20.37%
Retained Earnings	-388.18	-368.67	-332.77	-312	-290.52
Comprehensive Income	0.06	0.03	-0.01	0	0.04
Shareholders' Equity	13.39	29.33	55.8	18.61	14.56
Net Cash / Debt	14.07	27.98	42.76	10.97	3.53
Net Cash / Debt Growth	-49.71%	-34.56%	289.77%	211.09%	-80.62%
Net Cash Per Share	1.56	3.92	7.88	5.15	2.42
Working Capital	10.85	26.74	45.18	12.07	8.34
Book Value Per Share	1.48	4.11	10.28	8.73	10.00

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).